# Safety and Intake Effect of EPs® 7630 (an Extract of the Roots of Pelargonium Sidoides)

> **NCT02174653** · PHASE3 · COMPLETED · sponsor: **Dr. Willmar Schwabe GmbH & Co. KG** · enrollment: 720 (actual)

## Conditions studied

- Common Cold

## Interventions

- **DRUG:** EPs® 7630
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02174653
- **Lead sponsor:** Dr. Willmar Schwabe GmbH & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-07
- **Final completion:** 2016-08
- **Target enrollment:** 720 (ACTUAL)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02174653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02174653, "Safety and Intake Effect of EPs® 7630 (an Extract of the Roots of Pelargonium Sidoides)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02174653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*